BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35169126)

  • 21. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
    Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
    Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
    Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
    Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
    Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
    Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOR1 Suppresses Cancer Stem-Like Cells Properties of Tumor Cells via the Inhibition of the AKT-GSK-3β-Wnt/β-catenin-ALDH1A1 Signal Circuit.
    Wang W; Yi M; Chen S; Li J; Zhang H; Xiong W; Li G; Li X; Xiang B
    J Cell Physiol; 2017 Oct; 232(10):2829-2840. PubMed ID: 27891591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma.
    Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW
    BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation.
    Lin CH; Chao LK; Hung PH; Chen YJ
    Int J Clin Exp Pathol; 2014; 7(5):2372-81. PubMed ID: 24966947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients.
    He JY; Han P; Zhang Y; Liu YD; Song SJ; Feng GK; An Y; Zhou AJ; Wang HB; Yuan L; Lin ZR; Xia TL; Li MZ; Liu YM; Huang XM; Zhang H; Zhong Q
    J Mol Med (Berl); 2018 Apr; 96(3-4):265-279. PubMed ID: 29327067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis.
    Chu Q; Huang H; Huang T; Cao L; Peng L; Shi S; Zheng L; Xu L; Zhang S; Huang J; Li X; Qian C; Huang B
    Cell Death Dis; 2016 Nov; 7(11):e2456. PubMed ID: 27809309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy.
    Wei P; Niu M; Pan S; Zhou Y; Shuai C; Wang J; Peng S; Li G
    Stem Cell Res Ther; 2014; 5(2):44. PubMed ID: 25158069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
    Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.
    Kong QL; Hu LJ; Cao JY; Huang YJ; Xu LH; Liang Y; Xiong D; Guan S; Guo BH; Mai HQ; Chen QY; Zhang X; Li MZ; Shao JY; Qian CN; Xia YF; Song LB; Zeng YX; Zeng MS
    PLoS Pathog; 2010 Jun; 6(6):e1000940. PubMed ID: 20532215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Coding RNA Pvt1 Promotes Cancer Stem Cell-Like Traits in Nasopharyngeal Cancer via Inhibiting miR-1207.
    Cui M; Chang Y; Fang QG; Du W; Wu JF; Wang JH; Liu ST; Luo SX
    Pathol Oncol Res; 2019 Oct; 25(4):1411-1422. PubMed ID: 30141114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
    PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Zhu Q; Zhang Q; Gu M; Zhang K; Xia T; Zhang S; Chen W; Yin H; Yao H; Fan Y; Pan S; Xie H; Liu H; Cheng T; Zhang P; Zhang T; You B; You Y
    Autophagy; 2021 Jul; 17(7):1667-1683. PubMed ID: 32627648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flotillin-2 promotes cell proliferation via activating the c-Myc/BCAT1 axis by suppressing miR-33b-5p in nasopharyngeal carcinoma.
    Liu R; Liu J; Wu P; Yi H; Zhang B; Huang W
    Aging (Albany NY); 2021 Mar; 13(6):8078-8094. PubMed ID: 33744853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
    Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
    Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed.
    Luo W; Yao K
    PLoS One; 2013; 8(12):e83135. PubMed ID: 24349446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.
    Chen RH; Du Y; Han P; Wang HB; Liang FY; Feng GK; Zhou AJ; Cai MY; Zhong Q; Zeng MS; Huang XM
    Oncotarget; 2016 Mar; 7(13):16910-22. PubMed ID: 26919245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD166 promotes cancer stem cell-like phenotype via the EGFR/ERK1/2 pathway in the nasopharyngeal carcinoma cell line CNE-2R.
    Chen X; Liang R; Lin H; Chen K; Chen L; Tian G; Zhu X
    Life Sci; 2021 Feb; 267():118983. PubMed ID: 33383046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
    Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
    Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.